| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |